FDA to review Vytorin results

Jan 26, 2008

The U.S. Food and Drug Administration said it is conducting a review of the cholesterol drug Vytorin based on preliminary results from a recent study.

The agency said it will review Merck and Schering Plough Pharmaceuticals' recent trial once the FDA receives the final study results on the drug, which is a combination of Zetia (ezetimibe) and Zocor (simvastatin) in one tablet.

Merck and Schering Plough last week released data showing that the combination drug failed to slow progression of heart disease better than Zocor, which is less expensive.

The FDA said that study was not designed to detect any difference in risk of having a heart attack or stroke between the two treatments. The agency said an ongoing trial is designed to evaluate the effect of Vytorin versus Zocor on heart disease and stroke.

Merck issued a statement Friday in support of the the controversial clinical trial. "We stand behind Vytorin and Zetia and stand behind our science that has brought these cholesterol-lowering medications to millions of people around the world," Peter S. Kim, president of Merck Research Laboratories, said.

Copyright 2008 by United Press International

Explore further: Seniors successfully withdraw from meds

add to favorites email to friend print save as pdf

Related Stories

A new quality control pathway in the cell

45 minutes ago

Proteins are important building blocks in our cells and each cell contains millions of different protein molecules. They are involved in everything from structural to regulatory aspects in the cell. Proteins are constructed ...

NASA marks Polo for a hurricane

55 minutes ago

Hurricane Polo still appears rounded in imagery from NOAA's GOES-West satellite, but forecasters at the National Hurricane Center expect that to change.

NASA sees Hurricane Edouard enter cooler waters

56 minutes ago

NASA's Tropical Rainfall Measuring Mission or TRMM satellite and Aqua satellite gathered data on Hurricane Edouard's rainfall, clouds and waning power is it continued moving northward in the Atlantic into ...

Recommended for you

Seniors successfully withdraw from meds

Sep 19, 2014

Elderly people have proved receptive to being de-prescribed medications, as part of a trial aimed at assessing the feasibility of withdrawal of medications among older people.

Flu vaccine for expectant moms a top priority

Sep 18, 2014

Only about half of all pregnant women in the U.S. get a flu shot each season, leaving thousands of moms-to-be and their babies at increased risk of serious illness.

Experts want restrictions on testosterone drug use (Update)

Sep 17, 2014

Federal health experts said Wednesday there is little evidence that testosterone-boosting drugs are effective for treating common signs of aging in men and that their use should be narrowed to exclude millions of Americans ...

User comments : 0